Summary

The use of multimodal imaging is increasing, with the hope that it will improve patient selection for endovascular stroke treatment. This article discusses the effects of time delays on outcomes and hemorrhage rates in patients who receive noncontrast computed tomography only or multimodal CT imaging, as well as the DIFFUSE-2 and Multi MERCI Trials.